Application of shared Mechanism Therapies on Emotion in Patient With Chronic disease With Comorbidity

How to cite

nazari, nabi. 2019. "Application of shared Mechanism Therapies on Emotion in Patient With Chronic disease With Comorbidity." AEA RCT Registry. AEARCTR-0004435. https://doi.org/10.1257/rct.4435-18.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

nabi nazari*

* Primary investigator

Registry ID
AEARCTR-0004435
DOI
https://doi.org/10.1257/rct.4435-18.0
First registered
Last updated
Status
Completed
Trial dates
2018-11-09 – 2019-08-10
Countries
Iran (Islamic Republic of) (tehran,hamedan)
JEL codes
Efficacy of Transdiagnostic Group Therapy
Secondary IDs
Regulation and emotion regulation
Registry record
http://www.socialscienceregistry.org/trials/4435

Abstract

Abstract
The objective of this study was to investigate the effectiveness of The Application of shared Mechanism Therapies on Emotion in Patient With Chronic disease With Comorbidity
Anxiety is highly comorbid with depression, but little is known about the impact of anxiety disorders on the effectiveness of empirically supported psychotherapies for depression. We examined such outcomes for people.The prevalence of both anxiety and depressive the group examined in this study, in which lifetime prevalence and MDD is around 50% . As in medically healthy people, the consequences of these disorders for people with MS include higher risk for suicide .

Intervention

The purpose of this study was to assess the efficacy of the Application of shared Mechanism Therapies cognitive behavior therapy (CBT) as a treatment for multiple sclerosis (MS) fatigue on Emotion in Patient With Chronic disease With Comorbidity . A randomized controlled design was used where 72 patients with MS fatigue were randomly assigned to 14 weekly sessions of tCBT . Participants were assessed before and after treatment, and at 3 months after post-treatment.

Experimental design

The inclusion criteria included:
1. Diagnosis of MS at least 18 years of age
2. Fluent in Persian,
4. Meet scid

5. Received at least one self-report rch.
6. Fill and signature consent
7. Medical agreement for participation

Exclusion criteria included
1. The initial diagnosis of other psychiatric diagnoses, compensatory behaviors or cleansing,
2. Other Chronic physical illnesses (such as insulin-dependent diabetes and chemotherapy for cancer)
3. Pregnancy or breast feeding
4. Evidence of current or past schizophrenia, psychosis, or organic mental disorder, bipolar disorder, or organic mental disorder
6. Drug abuse history
7. Absenteeism

8. Receiving psychological interventions during one last year.
9. Presence of comorbid neurological disorders such as Alzheimer, Parkinson's disease, Dementia

Design details

Randomization method
computerized The block size of 6
Randomization unit
individual
Clusters
36 clinics
Observations
130 women
Arms
The sample size was calculated using G-POWER
Primary outcomes
Transdiagnostic Therapy approach is practical in increasing emotion regulation (ERQ scores) and decreasing the difficulties in Emotion Therapy was effective in decreasing anxiety and depression symptoms and Difficulties in Emotion Regulation among subjects in the post-test stage
Secondary outcomes
Scid Hads Pswq Ders Erq

Cited by

No citation data available for this registration yet.

Keywords